BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$484M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$450M |
| 3 |
UnitedHealth
UNH
|
+$430M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
Analog Devices
ADI
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$552M |
| 3 |
Netflix
NFLX
|
+$322M |
| 4 |
PepsiCo
PEP
|
+$291M |
| 5 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.39% |
| 2 | Financials | 8.43% |
| 3 | Healthcare | 8.12% |
| 4 | Consumer Discretionary | 8.06% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNAI
4751
Lunai Bioworks
LNAI
$10.2M
| $3K | ﹤0.01% |
69
-141
| -67% | -$9.02K |
|
4752
Verde Clean Fuels
VGAS
$28.2M
| $2.98K | ﹤0.01% |
891
-266
| -23% | -$1.02K |
|
4753
Nautilus Biotechnolgy
NAUT
$113M
| $2.98K | ﹤0.01% |
3,457
-3,793
| -52% | -$5.64K |
|
4754
Corvus Pharmaceuticals
CRVS
$1.27B
| $2.97K | ﹤0.01% |
933
+72
| +8% | +$339 |
|
4755
Actinium Pharmaceuticals
ATNM
$30.2M
| $2.95K | ﹤0.01% |
1,833
-3,911
| -68% | -$4.96K |
|
|
SOGP
4756
Sound Group
SOGP
$48.1M
| $2.95K | ﹤0.01% |
1,340
+400
| +43% | +$852 |
|
4757
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
| $2.95K | ﹤0.01% |
+40
| New | +$2.87K |
|
|
TBNK
4758
DELISTED
Territorial Bancorp Inc.
TBNK
| $2.91K | ﹤0.01% |
347
| – | – |
|
|
AKYA
4759
DELISTED
Akoya BioSciences
AKYA
| $2.9K | ﹤0.01% |
2,084
-2,179
| -51% | -$4.77K |
|
4760
Ispire Technology
ISPR
$91.3M
| $2.89K | ﹤0.01% |
1,059
-859
| -45% | -$3.63K |
|
4761
Assembly Biosciences
ASMB
$594M
| $2.89K | ﹤0.01% |
302
| – | – |
|
4762
Mitsubishi UFJ Financial
MUFG
$260B
| $2.86K | ﹤0.01% |
210
| – | – |
|
|
HLVX
4763
DELISTED
HilleVax
HLVX
| $2.84K | ﹤0.01% |
1,961
-2,402
| -55% | -$4.44K |
|
|
UHG
4764
DELISTED
United Homes Group
UHG
| $2.84K | ﹤0.01% |
1,015
-291
| -22% | -$1.13K |
|
4765
Purple Innovation
PRPL
$28.7M
| $2.76K | ﹤0.01% |
146
-230
| -61% | -$5.3K |
|
4766
KORU Medical Systems
KRMD
$154M
| $2.72K | ﹤0.01% |
1,070
-58
| -5% | -$215 |
|
4767
Acrivon Therapeutics
ACRV
$79.2M
| $2.71K | ﹤0.01% |
1,336
-605
| -31% | -$3.26K |
|
4768
PepGen
PEPG
$206M
| $2.68K | ﹤0.01% |
1,907
-477
| -20% | -$982 |
|
|
CMPS
4769
Compass Pathways
CMPS
$1.84B
| $2.67K | ﹤0.01% |
933
+251
| +37% | +$964 |
|
|
ADAG
4770
Adagene
ADAG
$246M
| $2.62K | ﹤0.01% |
1,700
-3,000
| -64% | -$5.61K |
|
4771
Alto Neuroscience
ANRO
$1.26B
| $2.6K | ﹤0.01% |
1,205
-41,315
| -97% | -$148K |
|
4772
CervoMed
CRVO
$39.6M
| $2.6K | ﹤0.01% |
284
-13,489
| -98% | -$51.4K |
|
4773
Red Cat Holdings
RCAT
$1.56B
| $2.59K | ﹤0.01% |
+441
| New | +$3.53K |
|
4774
Shattuck Labs
STTK
$735M
| $2.58K | ﹤0.01% |
2,715
-5,224
| -66% | -$6.44K |
|
4775
Global X S&P 500 Covered Call ETF
XYLD
$3.28B
| $2.57K | ﹤0.01% |
65
-26,357
| -100% | -$1.09M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2025 Portfolio in Review
As of Q1 2025, BNP Paribas Financial Markets held 5,672 positions worth $170B, down 4.7% from $178B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets's Q1 2025 filing shows 266 new, 2,026 increased, 2,595 reduced and 297 closed positions. Its largest new stake was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.79B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- BNP Paribas Financial Markets's largest Q1 2025 buy was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M.
- BNP Paribas Financial Markets added most to iShares MSCI USA Quality Factor ETF in Q1 2025, an estimated $484M increase.
- BNP Paribas Financial Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.79B.
- BNP Paribas Financial Markets fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q1 2025, selling an estimated $83.2M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $170B portfolio in Q1 2025.
- BNP Paribas Financial Markets opened 266 new positions and closed 297 in Q1 2025.
- BNP Paribas Financial Markets's portfolio value fell 4.7% quarter-over-quarter to $170B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.